SODIUM SULFACETAMIDE, SULFUR

openFDA label record#

Cross-check layer: This is openFDA JSON-derived label data. Use the corresponding DailyMed SPL as the canonical label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: SODIUM SULFACETAMIDE, SULFUR
Generic name: SODIUM SULFACETAMIDE 8% SULFUR 4%
Manufacturer: Aspen Medical LLC
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 4ba94e96-b107-77fe-e063-6394a90aa980
SPL ID: 4ba947e2-c5dc-e7f7-e063-6294a90aea33
Version: 1
Effective date: 2026-02-21
Source export date: 2026-08-01
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-08-01/0689a4374f1490600b5244071db3b04bd3bbc29ceda7a856edb8225323adf20a/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: bdd1454d0606b622b70458a306b8a10d8a8787db06fd9f46e69c7f7a4524b630
Import run: 20260801T225920Z
Imported at: 2026-08-01 22:59:31

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		SODIUM SULFACETAMIDE, SULFUR	openfda.brand_name
generic name		SODIUM SULFACETAMIDE 8% SULFUR 4%	openfda.generic_name
manufacturer name		Aspen Medical LLC	openfda.manufacturer_name
ndc	package	87026-203-16	openfda.package_ndc
ndc	product	87026-203	openfda.product_ndc
ndc11	package	87026020316	derived:openfda.package_ndc
rxcui		1010234	openfda.rxcui
spl id		4ba947e2-c5dc-e7f7-e063-6294a90aea33	id
spl set id		4ba94e96-b107-77fe-e063-6394a90aa980	set_id
unii		4NRT660KJQ	openfda.unii
unii		70FD1KFU70	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Although rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

Although rare, sodium sulfacetamide may cause local irritation. Call your doctor for medical advice about side effects.